LSPedia and Pharma Logistics Announce Strategic Partnership to Revolutionize Pharmaceutical Reverse Logistics and Supply Chain Visibility

Press Statements

Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan

6th November 2020

Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate, mRNA-1273,...

U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment of COVID-19

by Content Team

6th November 2020

U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment of COVID-19

Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury for the treatment of patients with...

Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan

by Content Team

6th November 2020

Lilly, Incyte's Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen

Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate, mRNA-1273,...

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.

by Content Team

5th November 2020

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.

Johnson & Johnson announced today that it is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of...

Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test

by Content Team

5th November 2020

Pfizer and BioNTech Announce Agreement with the UK 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Merck, a leading science and technology company, announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA,...

Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 to Japan

by Content Team

5th November 2020

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines...